Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor

scientific article

Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/SJ.BJP.0705118
P932PMC publication ID1573729
P698PubMed publication ID12642384
P5875ResearchGate publication ID10852148

P2093author name stringCharles H V Hoyle
Assumpta Peral
Teresa Peláez
Jesus Pintor
P2860cites workEffect of melatonin on intraocular pressureQ68503508
Diurnal rhythms of immunoreactive melatonin in the aqueous humor and serum of male pigmented rabbitsQ68608116
Localization of 2-[125I]iodomelatonin binding sites in mammalian retinaQ70147223
Effects of brimonidine on aqueous humor dynamics in human eyesQ71559414
Melatonin acts on the nucleus accumbens to increase acetylcholine release and modify the motor activity pattern of ratsQ73342037
The analgesic effects of peripheral and central administration of melatonin in ratsQ74254230
8OH-DPAT-Induced ocular hypotension: sites and mechanisms of actionQ78088255
Characterization of 2-[125I]iodomelatonin binding sites in Syrian hamster peripheral organsQ28138056
Actions of melatonin in the reduction of oxidative stress. A reviewQ34074485
Investigation into the contractile response of melatonin in the guinea-pig isolated proximal colon: the role of 5-HT4 and melatonin receptorsQ35026489
Localization and function of dopamine in the adult vertebrate retinaQ35222963
Mammalian pineal melatonin: a clock for all seasonsQ38709987
Melatonin receptors: are there multiple subtypes?Q40532109
Melatonin effects on the cytoskeletal organization of MDCK and neuroblastoma N1E-115 cellsQ41755819
The presence of functional melatonin receptors in the iris-ciliary processes of the rabbit eye.Q42488482
Identification of the melatonin-binding site MT3 as the quinone reductase 2.Q42630663
Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbitsQ43566827
Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2 .Q43593899
Melatonin receptor mRNA and protein expression in Xenopus laevis nonpigmented ciliary epithelial cellsQ43826185
Flesinoxan, a 5-HT1A receptor agonist/alpha 1-adrenoceptor antagonist, lowers intraocular pressure in NZW rabbitsQ43882842
Involvement of nitric oxide in the ocular hypotensive action of nipradilolQ43929182
Reversal of morphine tolerance and dependence by melatonin: possible role of central and peripheral benzodiazepine receptorsQ48162316
The chick retinal melatonin receptor revisited: localization and modulation of agonist binding with guanine nucleotidesQ48888829
The effects of melatonin on vasopressin secretion in vivo: interactions with acetylcholine and prostaglandins.Q51552400
Melatonin agonists induce phosphoinositide hydrolysis in Xenopus laevis melanophores.Q54565531
The ciliary body--the third organ found to synthesize indoleamines in humansQ67540977
Aqueous humor cyclic AMP and circadian elevation of intraocular pressure in rabbitsQ68276769
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)831-836
P577publication date2003-03-01
P1433published inBritish Journal of PharmacologyQ919631
P1476titleOcular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor
P478volume138

Reverse relations

cites work (P2860)
Q98577688Changes in melatonin receptor expression in a murine model of glaucoma
Q38949654Diadenosine tetraphosphate induces tight junction disassembly thus increasing corneal epithelial permeability
Q38584194Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions
Q52739208Docking studies for melatonin receptors.
Q53628648Effect of Melatonin and 5-Methoxycarbonylamino-N-Acetyltryptamine on the Intraocular Pressure of Normal and Glaucomatous Mice.
Q37847182Emerging drugs for ocular hypertension
Q38229317Expression and putative functions of melatonin receptors in malignant cells and tissues
Q36282807Functional MT1 and MT2 melatonin receptors in mammals
Q93551696G Protein-Coupled Receptors
Q54337814Involvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NAT.
Q93498531Melatonin
Q64979686Melatonin MT1 and MT2 Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle.
Q34636280Melatonin inhibits tachykinin NK2 receptor‐triggered 5‐HT release from guinea pig isolated colonic mucosa
Q41768470Melatonin receptor agonist-induced reduction of SNP-released nitric oxide and cGMP production in isolated human non-pigmented ciliary epithelial cells.
Q36291423Melatonin: an underappreciated player in retinal physiology and pathophysiology
Q38190064New therapeutic targets for intraocular pressure lowering.
Q38031910Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential
Q41992739Removal of melatonin receptor type 1 increases intraocular pressure and retinal ganglion cells death in the mouse.
Q88040597Seasonal Reproduction in Vertebrates: Melatonin Synthesis, Binding, and Functionality Using Tinbergen's Four Questions
Q37165143Seasonal changes of 24-hour intraocular pressure rhythm in healthy Shanghai population
Q34601286Serotonin levels in aqueous humor of patients with primary open-angle glaucoma
Q38709300TRPV4 Stimulation Induced Melatonin Secretion by Increasing Arylalkymine N-acetyltransferase (AANAT) Protein Level
Q30486707The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
Q37137215The effects of melatonin on anxiety and pain scores of patients, intraocular pressure, and operating conditions during cataract surgery under topical anesthesia.
Q39402838The role and therapeutic potential of melatonin in age-related ocular diseases.
Q36965736The role of melatonin in anaesthesia and critical care
Q37809108The role of melatonin in glaucoma: implications concerning pathophysiological relevance and therapeutic potential
Q28266443Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy

Search more.